46 results on '"Lee, Vincent W. S."'
Search Results
2. Matrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cells
- Author
-
Zhao, Ye, Qiao, Xi, Wang, Lihua, Tan, Tian Kui, Zhao, Hong, Zhang, Yun, Zhang, Jianlin, Rao, Padmashree, Cao, Qi, Wang, Yiping, Wang, Ya, Wang, Yuan Min, Lee, Vincent W. S., Alexander, Stephen I., Harris, David C. H., and Zheng, Guoping
- Published
- 2016
- Full Text
- View/download PDF
3. IL-25 Induces M2 Macrophages and Reduces Renal Injury in Proteinuric Kidney Disease
- Author
-
Cao, Qi, Wang, Changqi, Zheng, Dong, Wang, Ya, Lee, Vincent W. S., Wang, Yuan Min, Zheng, Guoping, Tan, Thian Kui, Yu, Di, Alexander, Stephen I., Harris, David C. H., and Wang, Yiping
- Published
- 2011
- Full Text
- View/download PDF
4. Adriamycin nephropathy in severe combined immunodeficient (SCID) mice
- Author
-
Lee, Vincent W. S., Wang, Yiping, Qin, Xiaohong, Wang, Ying, Zheng, Guoping, Mahajan, Deepika, Coombes, Jason, Rangan, Gopala, Alexander, Steven I., and Harris, David C. H.
- Published
- 2006
5. Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation
- Author
-
Wang, Ruifeng, primary, Chen, Titi, additional, Wang, Chengshi, additional, Zhang, Zhiqiang, additional, Wang, Xin Maggie, additional, Li, Qing, additional, Lee, Vincent W S, additional, Wang, Yuan Min, additional, Zheng, Guoping, additional, Alexander, Stephen I, additional, Wang, Yiping, additional, Harris, David C H, additional, and Cao, Qi, additional
- Published
- 2018
- Full Text
- View/download PDF
6. Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation.
- Author
-
Wang, Ruifeng, Chen, Titi, Wang, Chengshi, Zhang, Zhiqiang, Wang, Xin Maggie, Li, Qing, Lee, Vincent W S, Wang, Yuan Min, Zheng, Guoping, Alexander, Stephen I, Wang, Yiping, Harris, David C H, and Cao, Qi
- Subjects
CHRONIC kidney failure ,T cells ,FOCAL segmental glomerulosclerosis ,RENAL fibrosis ,PROTEIN-tyrosine kinases - Abstract
Background Chronic kidney disease (CKD) is a global public health problem, which lacks effective treatment. Previously, we have shown that CD103
+ dendritic cells (DCs) are pathogenic in adriamycin nephropathy (AN), a model of human focal segmental glomerulosclerosis (FSGS). Fms-like tyrosine kinase 3 (Flt3) is a receptor that is expressed with high specificity on tissue resident CD103+ DCs. Methods To test the effect on CD103+ DCs and kidney injury of inhibition of Flt3, we used a selective Flt3 inhibitor (AC220) to treat mice with AN. Results Human CD141+ DCs, homologous to murine CD103+ DCs, were significantly increased in patients with FSGS. The number of kidney CD103+ DCs, but not CD103− DCs or plasmacytoid DCs, was significantly decreased in AN mice after AC220 administration. Treatment with AC220 significantly improved kidney function and reduced kidney injury and fibrosis in AN mice. AC220-treated AN mice had decreased levels of inflammatory cytokines and chemokines, tumor necrosis factor-α, interleukin (IL)-1β, IL-6, CCL2 and CCL5 and reduced kidney infiltration of CD4 T cells and CD8 T cells. The protective effect of AC220 was associated with its suppression of CD103+ DCs-mediated CD8 T cell proliferation and activation in AN mice. Conclusion Flt3 inhibitor AC220 effectively reduced kidney injury in AN mice, suggesting that this inhibitor might be a useful pharmaceutical agent to treat CKD. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
7. DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice
- Author
-
Zhou, Jimmy Jianheng, primary, Wang, Yuan Min, additional, Lee, Vincent W. S., additional, Zhang, Geoff Yu, additional, Medbury, Heather, additional, Williams, Helen, additional, Wang, Ya, additional, Tan, Thian Kui, additional, Harris, David C. H., additional, Alexander, Stephen I., additional, and Durkan, Anne M., additional
- Published
- 2018
- Full Text
- View/download PDF
8. Therapeutic potential of regulatory macrophages generated from peritoneal dialysate in adriamycin nephropathy
- Author
-
Cao, Qi, primary, Wang, Yiping, additional, Wang, Changqi, additional, Wang, Xin M., additional, Lee, Vincent W. S., additional, Zheng, Guoping, additional, Zhao, Ye, additional, Alexander, Stephen I., additional, and Harris, David C. H., additional
- Published
- 2018
- Full Text
- View/download PDF
9. Therapeutic potential of regulatory macrophages generated from peritoneal dialysate in adriamycin nephropathy.
- Author
-
Qi Cao, Yiping Wang, Changqi Wang, Wang, Xin M., Lee, Vincent W. S., Guoping Zheng, Ye Zhao, Alexander, Stephen I., and Harris, David C. H.
- Subjects
KIDNEY disease treatments ,PERITONEAL dialysis ,CELLULAR therapy - Abstract
Cell therapy using macrophages requires large amounts of cells, which are difficult to collect from patients. Patients undergoing peritoneal dialysis (PD) discard huge numbers of peritoneal macrophages in dialysate daily. Macrophages can be modulated to become regulatory macrophages, which have shown great promise as a therapeutic strategy in experimental kidney disease and human kidney transplantation. This study aimed to examine the potential of using peritoneal macrophages (PMs) from peritoneal dialysate to treat kidney disease. Monocytes/macrophages accounted for >40% of total peritoneal leukocytes in both patients and mice undergoing PD. PMs from patients and mice undergoing PD were more mature than peripheral monocytes/macrophages, as shown by low expression of C-C motif chemokine receptor 2 (CCR2) and morphological changes during in vitro culture. PMs from patients and mice undergoing PD displayed normal macrophage function and could be modulated into a regulatory (M2) phenotype. In vivo, adoptive transfer of peritoneal M2 macrophages derived from PD mice effectively protected against kidney injury in mice with adriamycin nephropathy (AN). Importantly, the transfused peritoneal M2 macrophages maintained their M2 phenotype in kidney of AN mice. In conclusion, PMs derived from patients and mice undergoing PD exhibited conventional macrophage features. Peritoneal M2 macrophages derived from PD mice are able to reduce kidney injury in AN, suggesting that peritoneal macrophages from patients undergoing PD may have the potential for clinical therapeutic application. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Adriamycin Nephropathy in BALB/c Mice
- Author
-
Wang, Yuan Min, primary, Wang, Yiping, additional, Harris, David C. H., additional, Alexander, Stephen I., additional, and Lee, Vincent W. S., additional
- Published
- 2015
- Full Text
- View/download PDF
11. Matrix metalloproteinase 9-dependent Notch signaling contributes to kidney fibrosis through peritubular endothelial-mesenchymal transition.
- Author
-
Ye Zhao, Xi Qiao, Thian Kui Tan, Hong Zhao, Yun Zhang, Lixin Liu, Jianlin Zhang, Lihua Wang, Qi Cao, Yiping Wang, Ya Wang, Yuan Min Wang, Lee, Vincent W. S., Alexander, Stephen I., Harris, David C. H., and Guoping Zheng
- Subjects
CHRONIC kidney failure ,RENAL fibrosis ,ENDOTHELIAL cells ,MATRIX metalloproteinases ,CADHERINS - Abstract
Background: Endothelial cells are known to contribute to kidney fibrosis via endothelial-mesenchymal transition (EndoMT). Matrix metalloproteinase 9 (MMP-9) is known to be profibrotic. However, whether MMP-9 contributes to kidney fibrosis via EndoMT is unknown. Methods: Primary mouse renal peritubular endothelial cells (MRPECs) were isolated and treated by recombinant human transforming growth factor beta 1 (rhTGF-β1) with or without MMP-9 inhibitor or by recombinant human MMP-9 (rhMMP- 9) alone. Kidney fibrosis was induced by unilateral ureteral obstruction (UUO) in MMP-9 knockout (KO) and wide-type (WT) control mice. The effects of MMP-9 on EndoMT of MRPECs and kidney fibrosis were examined. Results: We showed that MRPECs underwent EndoMT after rhTGF-β1 treatment or in UUO kidney as evidenced by decreased expression of endothelial markers, vascular endothelial cadherin (VE-cadherin) and CD31, and increased levels of mesenchymal markers, a-smooth muscle actin (a-SMA) and vimentin. The expression of fibrosis markers was also upregulated significantly after rhTGF-β1 treatment in MRPECs. The EndoMT and fibrosis markers were significantly less in rhTGF-β1-treated MMP-9 KO MRPECs, whereas MMP-9 alone was sufficient to induce EndoMT in MRPECs. UUO kidney ofMMP-9 KO mice showed significantly less interstitial fibrosis and EndoMT in MRPECs. Notch signaling shown by Notch intracellular domain (NICD) was increased, while Notch-1 was decreased in rhTGF-β1-treated MRPECs of MMP-9WT but notMMP-9 KO mice. Inhibition ofMMP-9 or Notch signaling prevented rhTGF-β1- or rhMMP-9-induced a-SMA and NICD upregulation in MRPECs. UUO kidney of MMP-9 KOmice had less staining of Notch signaling transcription factor Hey-1 in VE-cadherin-positive MRPECs than WT controls. Conclusions: Our results demonstrate that MMP-9-dependent Notch signaling plays an important role in kidney fibrosis through EndoMT ofMRPECs. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. Association of β-catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF-β1
- Author
-
Tian, Xinrui, primary, Zhang, Jianlin, additional, Tan, Thian Kui, additional, Lyons, J. Guy, additional, Zhao, Hong, additional, Niu, Bo, additional, Lee, So Ra, additional, Tsatralis, Tania, additional, Zhao, Ye, additional, Wang, Ya, additional, Cao, Qi, additional, Wang, Changqi, additional, Wang, Yiping, additional, Lee, Vincent W. S., additional, Kahn, Michael, additional, Zheng, Guoping, additional, and Harris, David C. H., additional
- Published
- 2013
- Full Text
- View/download PDF
13. Matrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cells.
- Author
-
Ye Zhao, Xi Qiao, Lihua Wang, Tian Kui Tan, Hong Zhao, Yun Zhang, Jianlin Zhang, Rao, Padmashree, Qi Cao, Yiping Wang, Ya Wang, Yuan Min Wang, Lee, Vincent W. S., Alexander, Stephen I., Harris, David C. H., and Guoping Zheng
- Subjects
MATRIX metalloproteinases ,ENDOTHELIAL cells ,MYOFIBROBLASTS ,FIBROSIS ,NOTCH signaling pathway - Abstract
Background: Endothelial-mesenchymal transition (EndoMT) is a major source of myofibroblast formation in kidney fibrosis. Our previous study showed a profibrotic role for matrix metalloproteinase 9 (MMP-9) in kidney fibrosis via induction of epithelial-mesenchymal transition (EMT). Inhibition of MMP-9 activity reduced kidney fibrosis in murine unilateral ureteral obstruction. This study investigated whether MMP-9 also plays a role in EndoMT in human glomerular endothelial cells. Results: TGF-β1 (10 or 20 ng/ml) induced EndoMT in HKGECs as shown by morphological changes. In addition, VEcadherin and CD31 were significantly downregulated, whereas α-SMA, vimentin, and N-cadherin were upregulated. RT-PCR revealed that Snail, a known inducer of EMT, was upregulated. The MMP inhibitor GM6001 abrogated TGF-β1-induced EndoMT. Zymography indicated that MMP-9 was also upregulated in TGF-β1-treated HKGECs. Recombinant MMP-9 (2 μg/ml) induced EndoMT in HKGECs via Notch signaling, as evidenced by increased formation of the Notch intracellular domain (NICD) and decreased Notch 1. Inhibition of MMP-9 activity by its inhibitor showed a dose-dependent response in preventing TGF-β1-induced α-SMA and NICD in HKGECs, whereas inhibition of Notch signaling by γ-secretase inhibitor (GSI) blocked rMMP-9-induced EndoMT. Conclusions: Taken together, our results demonstrate that MMP-9 plays an important role in TGF-β1-induced EndoMT via upregulation of Notch signaling in HKGECs. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
14. Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Trials
- Author
-
Webster, Angela C., primary, Lee, Vincent W. S., additional, Chapman, Jeremy R., additional, and Craig, Jonathan C., additional
- Published
- 2006
- Full Text
- View/download PDF
15. Reconstitution of Acid-Denatured Holomyoglobin Studied by Time-Resolved Electrospray Ionization Mass Spectrometry
- Author
-
Lee, Vincent W. S., primary, Chen, Yu-Luan, additional, and Konermann, Lars, additional
- Published
- 1999
- Full Text
- View/download PDF
16. Association of β-catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF-β1.
- Author
-
Xinrui Tian, Jianlin Zhang, Thian Kui Tan, Lyons, J. Guy, Hong Zhao, Bo Niu, So Ra Lee, Tsatralis, Tania, Ye Zhao, Ya Wang, Qi Cao, Changqi Wang, Yiping Wang, Lee, Vincent W. S., Kahn, Michael, Guoping Zheng, and Harris, David C. H.
- Subjects
CATENINS ,ANTI-inflammatory agents ,TRANSFORMING growth factors ,EPITHELIAL cells ,MESENCHYMAL stem cells ,CELL transformation - Abstract
Transforming growth factor β1 (TGF-β1) is known to be both anti-inflammatory and profibrotic. Cross-talk between TGF-β/Smad and Wnt/β-catenin pathways in epithelial-mesenchymal transition (EMT) suggests a specific role for β-catenin in profibrotic effects of TGFβ1. However, no such mechanistic role has been demonstrated for β-catenin in the anti-inflammatory effects of TGF-β1. In the present study, we explored the role of β-catenin in the profibrotic and anti-inflammatory effects of TGF-β1 by using a cytosolic, but not membrane, β-catenin knockdown chimera (F-TrCP-Ecad) and the β-catenin/CBP inhibitor ICG-001. TGF-β1 induced nuclear Smad3/βcatenin complex, but not β-catenin/LEF-1 complex or TOP-flash activity, during EMT of C1.1 (renal tubular epithelial) cells. F-TrCPEcad selectively degraded TGF-β1-induced cytoplasmic β-catenin and blocked EMT of C1.1 cells. Both F-TrCP-Ecad and ICG-001 blocked TGF-β1-induced Smad3/β-catenin and Smad reporter activity in C1.1 cells, suggesting that TGF-β1-induced EMT depends on β-catenin binding to Smad3, but not LEF-1 downstream of Smad3, through canonical Wnt. In contrast, in J774 macrophages, the β-catenin level was low and was not changed by interferon-c (IFN-β) or lipopolysaccharide (LPS) with or without TGF-β1. TGF-β1 inhibition of LPS-induced TNF-α and IFN-γ-stimulated inducible NO synthase (iNOS) expression was not affected by F-TrCP-Ecad, ICG-001 or by overexpression of wild-type β-catenin in J774 cells. Inhibition of β-catenin by either F-TrCP-Ecad or ICG-001 abolished LiCl-induced TOP-flash, but not TGF-β1-induced Smad reporter, activity in J774 cells. These results demonstrate for the first time that β-catenin is required as a co-factor of Smad in TGF-β1-induced EMT of C1.1 epithelial cells, but not in TGF-β1 inhibition of macrophage activation. Targeting β-catenin may dissociate the TGF-β1 profibrotic and anti-inflammatory effects. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
17. Transfused Macrophages Ameliorate Pancreatic and Renal Injury in Murine Diabetes Mellitus.
- Author
-
Dong Zheng, Yiping Wang, Qi Cao, Lee, Vincent W. S., Guoping Zheng, Yan Sun, Tan, Thian K., Ya Wang, Alexander, Stephen I., and Harris, David C. H.
- Subjects
DIABETES ,KIDNEY injuries ,MACROPHAGES ,PHENOTYPES ,LABORATORY mice ,STREPTOZOTOCIN ,BLOOD sugar monitoring ,CYTOKINES - Abstract
Background: Alternatively activated macrophages (M2 macrophages) are able to reduce renal injury in murine adriamycin nephropathy. However, the effect of M2 macrophages in other renal diseases such as diabetic nephropathy remains unknown. Methods: Macrophages were separated from splenocytes and polarized with IL-4 and IL-13 into a protective phenotype. Mice underwent adoptive transfer with M2 macrophages, and then diabetes was induced by tail vein injection with streptozotocin (STZ). Blood glucose levels were monitored daily. Mice were sacrificed at week 10 after STZ. Renal function and histopathological injury were assessed quantitatively. Results: Transfused M2 macrophages accumulated progressively in kidneys for up to 10 weeks after STZ. Kidneys from diabetic mice transfused with M2 macrophages had less tubular atrophy, glomerular hypertrophy and interstitial expansion than did control diabetic mice. M2 macrophages suppressed the development of interstitial fibrosis. In addition, the degree of pancreatic islet injury, as assessed by insulin staining, haemoglobin A1c and blood glucose was reduced after transfusion of M2 macrophages. In vivo, activation of kidney endogenous macrophage cytokine expression was inhibited by M2 macrophages. Conclusion: Our findings show that M2 macrophages can protect against islet and renal injury in streptozotocin-induced diabetes, providing a potential therapeutic strategy for diabetes and diabetic nephropathy. Copyright © 2011 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
18. Sirolimus: Its role in nephrology (Review Article).
- Author
-
LEE, VINCENT W. S. and CHAPMAN, JEREMY R.
- Subjects
- *
RAPAMYCIN , *NEPHROLOGY , *IMMUNOSUPPRESSIVE agents , *BIOCHEMICAL mechanism of action , *CELL cycle , *CELL proliferation - Abstract
Sirolimus (Rapamycin, Wyeth Pharmaceuticals Australia Pty Ltd, Baulkham Hills, NSW, Australia) (SRL) has received increasing attention as an immunosuppressant in renal and other solid organ transplantation. Sirolimus is the first marketed agent in a new class of drugs with a novel mechanism of action. Sirolimus binds, like tacrolimus, to a member of the FK binding protein (FKBP) family. The SRL/FKBP complex binds to the protein kinase mTOR. Binding to mTOR blocks activation of signal transduction pathways causing arrest of the cell cycle in the G1 phase. It is now known that mTOR is a central regulator of cell growth and proliferation. The immunosuppressive properties of SRL are due primarily to blockade of interleukin-2 (IL-2)-induced proliferation of T cells. There is still much to be learnt about how best to use the drug. The key advantage over the current choice of immunosuppressive agents is the ability to preserve renal function and pathology while producing excellent rejection-free, graft survival rates. Thus, SRL may find its pivotal role as a calcineurin inhibitors replacement in patients whose grafts are affected by chronic allograft nephropathy. A second major driver for use may prove to be the impact of SRL on cancer incidence and prognosis. Studies still need to be performed to evaluate the best timing for commencement of SRL and the optimal dosage to minimize side-effects. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
19. Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage.
- Author
-
Thian Kui Tan, Guoping Zheng, Tzu-Ting Hsu, So Ra Lee, Jianlin Zhang, Ye Zhao, Xinrui Tian, Yiping Wang, Yuan Min Wang, Qi Cao, Ya Wang, Lee, Vincent W. S., Changqi Wang, Dong Zheng, Alexander, Stephen I., Thompson, Erik, and Harris, David C. H.
- Published
- 2013
- Full Text
- View/download PDF
20. Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease.
- Author
-
Zheng, Dong, Cao, Qi, Lee, Vincent W S, Wang, Ya, Zheng, Guoping, Wang, YuanMin, Tan, Thian Kui, Wang, Changqi, Alexander, Stephen I, Harris, David C H, and Wang, Yiping
- Subjects
- *
DENDRITIC cells , *T cells , *CELLULAR immunity , *IMMUNOLOGIC diseases , *IMMUNE response - Abstract
Plasmacytoid dendritic cells play important roles in inducing immune tolerance, preventing allograft rejection, and regulating immune responses in both autoimmune disease and graft-versus-host disease. In order to evaluate a possible protective effect of plasmacytoid dendritic cells against renal inflammation and injury, we purified these cells from mouse spleens and adoptively transferred lipopolysaccharide (LPS)-treated cells, modified ex vivo, into mice with adriamycin nephropathy. These LPS-treated cells localized to the kidney cortex and the lymph nodes draining the kidney, and protected the kidney from injury during adriamycin nephropathy. Glomerulosclerosis, tubular atrophy, interstitial expansion, proteinuria, and creatinine clearance were significantly reduced in mice with adriamycin nephropathy subsequently treated with LPS-activated plasmacytoid dendritic cells as compared to the kidney injury in mice given naive plasmacytoid dendritic cells. In addition, LPS-pretreated cells, but not naive plasmacytoid dendritic cells, convert CD4+CD25− T cells into Foxp3+ regulatory T cells and suppress the proinflammatory cytokine production of endogenous renal macrophages. This may explain their ability to protect against renal injury in adriamycin nephropathy. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
21. Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivo.
- Author
-
Cao, Qi, Wang, Yiping, Zheng, Dong, Sun, Yan, Wang, Changqi, Wang, Xin M, Lee, Vincent W S, Wang, Ya, Zheng, Guoping, Tan, Thian K, Wang, Yuan M, Alexander, Stephen I, and Harris, David C H
- Subjects
- *
BONE marrow diseases , *MACROPHAGES , *CELL proliferation , *PHENOTYPES , *DOXORUBICIN - Abstract
Alternatively activated macrophages (M2) regulate immune responses and ex vivo polarized splenic M2 are able to ameliorate renal injury including models of renal disease, such as adriamycin nephropathy. Whether M2 derived from other organs have similar protective efficacy is unknown. Here, we report adoptively transferred bone marrow M2 macrophages did not improve renal function or reduce renal injury in adriamycin nephropathy, whereas splenic M2 macrophages were protective. Bone marrow and splenic M2 macrophages showed similar regulatory phenotypes and suppressive functions in vitro. Within the inflamed kidney, suppressive phenotypes in bone marrow but not in splenic M2 macrophages, were dramatically reduced. Loss of the suppressive phenotype in bone marrow M2 was related to strong proliferation of bone marrow M2. Bone marrow M2 proliferation in vivo correlated with M-CSF expression by tubular cells in the inflamed kidney. Inhibition of M-CSF in vitro limited bone marrow M2 proliferation and prevented switch of phenotype. Proliferating cells derived from transfused bone marrow M2 were inflammatory rather than regulatory in their phenotype and function. Thus bone marrow in contrast to splenic M2 macrophages do not protect against renal structural and functional injury in murine adriamycin nephropathy. The failed renoprotection of bone marrow M2 is due to the switch of transfused M2 macrophages from a regulatory to an inflammatory phenotype. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
22. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease.
- Author
-
Lu, Junyu, Cao, Qi, Zheng, Dong, Sun, Yan, Wang, Changqi, Yu, Xiao, Wang, Ya, Lee, Vincent W S, Zheng, Guoping, Tan, Thian K., Wang, Xin, Alexander, Stephen I, Harris, David C H, and Wang, Yiping
- Subjects
- *
MACROPHAGES , *KIDNEY diseases , *ANTI-inflammatory agents , *DOXORUBICIN , *GLOMERULOSCLEROSIS - Abstract
Two types of alternatively activated macrophages, M2a induced by IL-4/IL-13 and M2c by IL-10/TGF-β, exhibit anti-inflammatory functions in vitro and protect against renal injury in vivo. Since their relative therapeutic efficacy is unclear, we compared the effects of these two macrophage subsets in murine adriamycin nephrosis. Both subsets significantly reduced renal inflammation and renal injury; however, M2c macrophages more effectively reduced glomerulosclerosis, tubular atrophy, interstitial expansion, and proteinuria than M2a macrophages. The M2c macrophages were also more effective than M2a in reduction of macrophage and CD4+ T-cell infiltration in kidney. Moreover, nephrotic mice treated with M2c had a greater reduction in renal fibrosis than those treated with M2a. M2c but not M2a macrophages induced regulatory T cells (Tregs) from CD4+CD25- T cells in vitro, and increased Treg numbers in local draining lymph nodes of nephrotic mice. To determine whether the greater protection with M2c was due to their capability to induce Tregs, the Tregs were depleted by PC61 antibody in nephrotic mice treated with M2a or M2c. Treg depletion diminished the superior effects of M2c compared to M2a in protection against renal injury, inflammatory infiltrates, and renal fibrosis. Thus, M2c are more potent than M2a macrophages in protecting against renal injury due to their ability to induce Tregs. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
23. Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury.
- Author
-
Cao Q, Wang R, Niu Z, Chen T, Azmi F, Read SA, Chen J, Lee VWS, Zhou C, Julovi S, Huang Q, Wang YM, Starkey MR, Zheng G, Alexander SI, George J, Wang Y, and Harris DCH
- Abstract
Background and Aims: Although type 2 innate lymphoid cells (ILC2s) were originally found to be liver-resident lymphocytes, the role and importance of ILC2 in liver injury remains poorly understood. In the current study, we sought to determine whether ILC2 is an important regulator of hepatic ischaemia/reperfusion injury (IRI)., Methods: ILC2-deficient mice (ICOS-T or NSG) and genetically modified ILC2s were used to investigate the role of ILC2s in murine hepatic IRI. Interactions between ILC2s and eosinophils or macrophages were studied in coculture. The role of human ILC2s was assessed in an immunocompromised mouse model of hepatic IRI., Results: Administration of IL-33 prevented hepatic IRI in association with reduction of neutrophil infiltration and inflammatory mediators in the liver. IL-33-treated mice had elevated numbers of ILC2s, eosinophils, and regulatory T cells. Eosinophils, but not regulatory T cells, were required for IL-33-mediated hepatoprotection in IRI mice. Depletion of ILC2s substantially abolished the protective effect of IL-33 in hepatic IRI, indicating that ILC2s play critical roles in IL-33-mediated liver protection. Adoptive transfer of ex vivo -expanded ILC2s improved liver function and attenuated histologic damage in mice subjected to IRI. Mechanistic studies combining genetic and adoptive transfer approaches identified a protective role of ILC2s through promoting IL-13-dependent induction of anti-inflammatory macrophages and IL-5-dependent elevation of eosinophils in IRI. Furthermore, in vivo expansion of human ILC2s by IL-33 or transfer of ex vivo -expanded human ILC2s ameliorated hepatic IRI in an immunocompromised mouse model of hepatic IRI., Conclusions: This study provides insight into the mechanisms of ILC2-mediated liver protection that could serve as therapeutic targets to treat acute liver injury., Impact and Implications: We report that type 2 innate lymphoid cells (ILC2s) are important regulators in a mouse model of liver ischaemia/reperfusion injury (IRI). Through manipulation of macrophage and eosinophil phenotypes, ILC2s mitigate liver inflammation and injury during liver IRI. We propose that ILC2s have the potential to serve as a therapeutic tool for protecting against acute liver injury and lay the foundation for translation of ILC2 therapy to human liver disease., Competing Interests: The authors declare that no conflicts of interest exist. Please refer to the accompanying ICMJE disclosure forms for further details., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
24. Factors Influencing Long-Term Patient and Allograft Outcomes in Elderly Kidney Transplant Recipients.
- Author
-
So S, Au EHK, Lim WH, Lee VWS, and Wong G
- Abstract
Introduction: Individuals aged ≥65 years are increasingly prevalent on the waitlist for kidney transplantation, yet evidence on recipient and donor factors that define optimal outcomes in elderly patients after kidney transplantation is scarce., Methods: We used multivariable Cox regression modeling to determine the factors associated with all-cause death, death with a functioning graft, and overall and death-censored graft survival, using data from the Australia and New Zealand Dialysis and Transplant (ANZDATA) registry., Results: A total of 802 kidney transplant recipients aged ≥65 years underwent their first transplantation between June 2006 and December 2016. Median age at transplantation was 68 years (interquartile range = 66-69 years). The 1-year and 5-year overall patient and graft survivals (95% confidence interval [CI]) were 95.1 (93.5-96.7) and 79.0 (75.1-82.9), and 92.9 (91.1-94.7) and 75.4 (71.3-79.5), respectively. Factors associated with higher risks of all-cause death included prevalent coronary artery disease (adjusted hazard ratio [95% confidence interval] = 1.47 [1.03-2.11]), cerebrovascular disease (1.99 [1.26-3.16]), increasing graft ischemic time (1.06 per hour [1.03-1.09]), donor age (1.02 per year [1.01-1.03]), delayed graft function (1.64 [1.13-2.39]), and peritoneal dialysis pretransplantation (1.71 [1.17-2.51])., Conclusion: Prevalent vascular disease and peritoneal dialysis as a pretransplantation dialysis modality are risk factors associated with poorer outcomes in transplant recipients aged ≥65 years. Careful selection and evaluation of potential candidates may improve graft and patient outcomes in older patients., (Crown Copyright © 2020 Published by Elsevier Inc. on behalf of the International Society of Nephrology.)
- Published
- 2020
- Full Text
- View/download PDF
25. Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia/reperfusion injury.
- Author
-
Cao Q, Wang R, Wang Y, Niu Z, Chen T, Wang C, Jin L, Huang Q, Li Q, Wang XM, Azmi F, Lee VWS, Wang YM, Zheng G, Alexander SI, and Harris DCH
- Subjects
- Adoptive Transfer, Animals, Cell Separation, Cells, Cultured, Coculture Techniques, Disease Models, Animal, Flow Cytometry, Homeodomain Proteins genetics, Humans, Interleukin-10 metabolism, Interleukin-2 antagonists & inhibitors, Interleukin-2 metabolism, Kidney blood supply, Kidney immunology, Kidney pathology, Lymphocyte Subsets metabolism, Lymphocyte Subsets transplantation, Macrophages immunology, Male, Mice, Mice, Knockout, Nephritis pathology, Primary Cell Culture, Reperfusion Injury immunology, Reperfusion Injury pathology, Transforming Growth Factor beta metabolism, Immunity, Innate, Kidney cytology, Lymphocyte Subsets immunology, Nephritis immunology, Reperfusion Injury complications
- Abstract
Innate lymphoid cells are a recently recognized group of immune cells with critical roles in tissue homeostasis and inflammation. Regulatory innate lymphoid cells are a newly identified subset of innate lymphoid cells, which play a suppressive role in the innate immune response, favoring the resolution of intestinal inflammation. However, the expression and role of regulatory innate lymphoid cells in kidney has not been reported. Here, we show that regulatory innate lymphoid cells are present in both human and mouse kidney, express similar surface markers and form a similar proportion of total kidney innate lymphoid cells. Regulatory innate lymphoid cells from kidney were expanded in vitro with a combination of IL-2, IL-7 and transforming growth factor-β. These cells exhibited immunosuppressive effects on innate immune cells via secretion of IL-10 and transforming growth factor-β. Moreover, treatment with IL-2/IL-2 antibody complexes (IL-2C) promoted expansion of regulatory innate lymphoid cells in vivo, and prevent renal ischemia/reperfusion injury in Rag-/- mice that lack adaptive immune cells including Tregs. Depletion of regulatory innate lymphoid cells with anti-CD25 antibody abolished the beneficial effects of IL-2C in the Rag-/- mice. Adoptive transfer of ex vivo expanded regulatory innate lymphoid cells improved renal function and attenuated histologic damage when given before or after induction of ischemia/reperfusion injury in association with reduction of neutrophil infiltration and induction of reparative M2 macrophages in kidney. Thus, our study shows that regulatory innate lymphoid cells suppress innate renal inflammation and ischemia/reperfusion injury., (Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
26. Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation.
- Author
-
Wang R, Chen T, Wang C, Zhang Z, Wang XM, Li Q, Lee VWS, Wang YM, Zheng G, Alexander SI, Wang Y, Harris DCH, and Cao Q
- Subjects
- Animals, Cytokines metabolism, Dendritic Cells drug effects, Humans, Kidney immunology, Kidney metabolism, Lymphocyte Activation drug effects, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Renal Insufficiency, Chronic immunology, Renal Insufficiency, Chronic metabolism, Renal Insufficiency, Chronic pathology, Antigens, CD metabolism, Benzothiazoles pharmacology, Dendritic Cells immunology, Integrin alpha Chains metabolism, Kidney drug effects, Lymphocyte Activation immunology, Phenylurea Compounds pharmacology, Renal Insufficiency, Chronic prevention & control, fms-Like Tyrosine Kinase 3 antagonists & inhibitors
- Abstract
Background: Chronic kidney disease (CKD) is a global public health problem, which lacks effective treatment. Previously, we have shown that CD103+ dendritic cells (DCs) are pathogenic in adriamycin nephropathy (AN), a model of human focal segmental glomerulosclerosis (FSGS). Fms-like tyrosine kinase 3 (Flt3) is a receptor that is expressed with high specificity on tissue resident CD103+ DCs., Methods: To test the effect on CD103+ DCs and kidney injury of inhibition of Flt3, we used a selective Flt3 inhibitor (AC220) to treat mice with AN., Results: Human CD141+ DCs, homologous to murine CD103+ DCs, were significantly increased in patients with FSGS. The number of kidney CD103+ DCs, but not CD103- DCs or plasmacytoid DCs, was significantly decreased in AN mice after AC220 administration. Treatment with AC220 significantly improved kidney function and reduced kidney injury and fibrosis in AN mice. AC220-treated AN mice had decreased levels of inflammatory cytokines and chemokines, tumor necrosis factor-α, interleukin (IL)-1β, IL-6, CCL2 and CCL5 and reduced kidney infiltration of CD4 T cells and CD8 T cells. The protective effect of AC220 was associated with its suppression of CD103+ DCs-mediated CD8 T cell proliferation and activation in AN mice., Conclusion: Flt3 inhibitor AC220 effectively reduced kidney injury in AN mice, suggesting that this inhibitor might be a useful pharmaceutical agent to treat CKD., (© The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
27. Therapeutic potential of regulatory macrophages generated from peritoneal dialysate in adriamycin nephropathy.
- Author
-
Cao Q, Wang Y, Wang C, Wang XM, Lee VWS, Zheng G, Zhao Y, Alexander SI, and Harris DCH
- Subjects
- Animals, Cell Plasticity, Cell Separation methods, Cells, Cultured, Cytokines metabolism, Disease Models, Animal, Humans, Inflammation Mediators metabolism, Kidney Diseases chemically induced, Kidney Diseases immunology, Kidney Diseases metabolism, Macrophages, Peritoneal immunology, Macrophages, Peritoneal metabolism, Male, Mice, Inbred BALB C, Phenotype, Time Factors, Adoptive Transfer, Dialysis Solutions, Doxorubicin, Kidney immunology, Kidney metabolism, Kidney pathology, Kidney Diseases prevention & control, Macrophages, Peritoneal transplantation, Peritoneal Dialysis
- Abstract
Cell therapy using macrophages requires large amounts of cells, which are difficult to collect from patients. Patients undergoing peritoneal dialysis (PD) discard huge numbers of peritoneal macrophages in dialysate daily. Macrophages can be modulated to become regulatory macrophages, which have shown great promise as a therapeutic strategy in experimental kidney disease and human kidney transplantation. This study aimed to examine the potential of using peritoneal macrophages (PMs) from peritoneal dialysate to treat kidney disease. Monocytes/macrophages accounted for >40% of total peritoneal leukocytes in both patients and mice undergoing PD. PMs from patients and mice undergoing PD were more mature than peripheral monocytes/macrophages, as shown by low expression of C-C motif chemokine receptor 2 (CCR2) and morphological changes during in vitro culture. PMs from patients and mice undergoing PD displayed normal macrophage function and could be modulated into a regulatory (M2) phenotype. In vivo, adoptive transfer of peritoneal M2 macrophages derived from PD mice effectively protected against kidney injury in mice with adriamycin nephropathy (AN). Importantly, the transfused peritoneal M2 macrophages maintained their M2 phenotype in kidney of AN mice. In conclusion, PMs derived from patients and mice undergoing PD exhibited conventional macrophage features. Peritoneal M2 macrophages derived from PD mice are able to reduce kidney injury in AN, suggesting that peritoneal macrophages from patients undergoing PD may have the potential for clinical therapeutic application.
- Published
- 2018
- Full Text
- View/download PDF
28. Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.
- Author
-
Cao Q, Wang Y, Niu Z, Wang C, Wang R, Zhang Z, Chen T, Wang XM, Li Q, Lee VWS, Huang Q, Tan J, Guo M, Wang YM, Zheng G, Yu D, Alexander SI, Wang H, and Harris DCH
- Subjects
- Amphiregulin metabolism, Animals, Female, Humans, Immunity, Innate, Interleukin-13 metabolism, Interleukin-4 metabolism, Kidney Diseases immunology, Kidney Diseases pathology, Lymphocyte Count, Macrophages immunology, Male, Mice, Recombinant Proteins therapeutic use, Reperfusion Injury immunology, Reperfusion Injury pathology, T-Lymphocytes, Regulatory immunology, Th2 Cells immunology, Interleukin-33 therapeutic use, Kidney Diseases prevention & control, Lymphocytes immunology, Lymphocytes metabolism, Reperfusion Injury prevention & control
- Abstract
The IL-33-type 2 innate lymphoid cell (ILC2) axis has an important role in tissue homeostasis, inflammation, and wound healing. However, the relative importance of this innate immune pathway for immunotherapy against inflammation and tissue damage remains unclear. Here, we show that treatment with recombinant mouse IL-33 prevented renal structural and functional injury and reduced mortality in mice subjected to ischemia-reperfusion injury (IRI). Compared with control-treated IRI mice, IL-33-treated IRI mice had increased levels of IL-4 and IL-13 in serum and kidney and more ILC2, regulatory T cells (Tregs), and anti-inflammatory (M2) macrophages. Depletion of ILC2, but not Tregs, substantially abolished the protective effect of IL-33 on renal IRI. Adoptive transfer of ex vivo -expanded ILC2 prevented renal injury in mice subjected to IRI. This protective effect associated with induction of M2 macrophages in kidney and required ILC2 production of amphiregulin. Treatment of mice with IL-33 or ILC2 after IRI was also renoprotective. Furthermore, in a humanized mouse model of renal IRI, treatment with human IL-33 or transfer of ex vivo -expanded human ILC2 ameliorated renal IRI. This study has uncovered a major protective role of the IL-33-ILC2 axis in renal IRI that could be potentiated as a therapeutic strategy., (Copyright © 2018 by the American Society of Nephrology.)
- Published
- 2018
- Full Text
- View/download PDF
29. Matrix metalloproteinase 9-dependent Notch signaling contributes to kidney fibrosis through peritubular endothelial-mesenchymal transition.
- Author
-
Zhao Y, Qiao X, Tan TK, Zhao H, Zhang Y, Liu L, Zhang J, Wang L, Cao Q, Wang Y, Wang Y, Wang YM, Lee VWS, Alexander SI, Harris DCH, and Zheng G
- Subjects
- Animals, Endothelium metabolism, Fibrosis metabolism, Humans, Kidney Diseases metabolism, Male, Mesoderm metabolism, Mice, Mice, Inbred BALB C, Mice, Knockout, Signal Transduction, Transforming Growth Factor beta1 metabolism, Ureteral Obstruction metabolism, Ureteral Obstruction pathology, Endothelium pathology, Fibrosis pathology, Kidney Diseases pathology, Matrix Metalloproteinase 9 metabolism, Mesoderm pathology, Receptors, Notch metabolism
- Abstract
Background: Endothelial cells are known to contribute to kidney fibrosis via endothelial-mesenchymal transition (EndoMT). Matrix metalloproteinase 9 (MMP-9) is known to be profibrotic. However, whether MMP-9 contributes to kidney fibrosis via EndoMT is unknown., Methods: Primary mouse renal peritubular endothelial cells (MRPECs) were isolated and treated by recombinant human transforming growth factor beta 1 (rhTGF-β1) with or without MMP-9 inhibitor or by recombinant human MMP-9 (rhMMP-9) alone. Kidney fibrosis was induced by unilateral ureteral obstruction (UUO) in MMP-9 knockout (KO) and wide-type (WT) control mice. The effects of MMP-9 on EndoMT of MRPECs and kidney fibrosis were examined., Results: We showed that MRPECs underwent EndoMT after rhTGF-β1 treatment or in UUO kidney as evidenced by decreased expression of endothelial markers, vascular endothelial cadherin (VE-cadherin) and CD31, and increased levels of mesenchymal markers, α-smooth muscle actin (α-SMA) and vimentin. The expression of fibrosis markers was also up-regulated significantly after rhTGF-β1 treatment in MRPECs. The EndoMT and fibrosis markers were significantly less in rhTGF-β1-treated MMP-9 KO MRPECs, whereas MMP-9 alone was sufficient to induce EndoMT in MRPECs. UUO kidney of MMP-9 KO mice showed significantly less interstitial fibrosis and EndoMT in MRPECs. Notch signaling shown by Notch intracellular domain (NICD) was increased, while Notch-1 was decreased in rhTGF-β1-treated MRPECs of MMP-9 WT but not MMP-9 KO mice. Inhibition of MMP-9 or Notch signaling prevented rhTGF-β1- or rhMMP-9-induced α-SMA and NICD upregulation in MRPECs. UUO kidney of MMP-9 KO mice had less staining of Notch signaling transcription factor Hey-1 in VE-cadherin-positive MRPECs than WT controls., Conclusions: Our results demonstrate that MMP-9-dependent Notch signaling plays an important role in kidney fibrosis through EndoMT of MRPECs., (© The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA.)
- Published
- 2017
- Full Text
- View/download PDF
30. α3 Integrin of Cell-Cell Contact Mediates Kidney Fibrosis by Integrin-Linked Kinase in Proximal Tubular E-Cadherin Deficient Mice.
- Author
-
Zheng G, Zhang J, Zhao H, Wang H, Pang M, Qiao X, Lee SR, Hsu TT, Tan TK, Lyons JG, Zhao Y, Tian X, Loebel DAF, Rubera I, Tauc M, Wang Y, Wang Y, Wang YM, Cao Q, Wang C, Lee VWS, Alexander SI, Tam PPL, and Harris DCH
- Subjects
- Animals, Blotting, Western, Cell Adhesion, Chromatin Immunoprecipitation, Disease Models, Animal, Fibrosis metabolism, Fibrosis pathology, Immunohistochemistry, Immunoprecipitation, Kidney Diseases metabolism, Kidney Tubules, Proximal metabolism, Kidney Tubules, Proximal pathology, Mice, Mice, Knockout, Microscopy, Electron, Transmission, Real-Time Polymerase Chain Reaction, Signal Transduction physiology, Cadherins deficiency, Integrin alpha3beta1 metabolism, Kidney Diseases pathology, Protein Serine-Threonine Kinases metabolism
- Abstract
Loss of E-cadherin marks a defect in epithelial integrity and polarity during tissue injury and fibrosis. Whether loss of E-cadherin plays a causal role in fibrosis is uncertain. α3β1 Integrin has been identified to complex with E-cadherin in cell-cell adhesion, but little is known about the details of their cross talk. Herein, E-cadherin gene (Cdh1) was selectively deleted from proximal tubules of murine kidney by Sglt2Cre. Ablation of E-cadherin up-regulated α3β1 integrin at cell-cell adhesion. E-cadherin-deficient proximal tubular epithelial cell displayed enhanced transforming growth factor-β1-induced α-smooth muscle actin (α-SMA) and vimentin expression, which was suppressed by siRNA silencing of α3 integrin, but not β1 integrin. Up-regulation of transforming growth factor-β1-induced α-SMA was mediated by an α3 integrin-dependent increase in integrin-linked kinase (ILK). Src phosphorylation of β-catenin and consequent p-β-catenin-Y654/p-Smad2 transcriptional complex underlies the transcriptional up-regulation of ILK. Kidney fibrosis after unilateral ureteric obstruction or ischemia reperfusion was increased in proximal tubule E-cadherin-deficient mice in comparison to that of E-cadherin intact control mice. The exacerbation of fibrosis was explained by the α3 integrin-dependent increase of ILK, β-catenin nuclear translocation, and α-SMA/proximal tubular-specific Cre double positive staining in proximal tubular epithelial cell. These studies delineate a nonconventional integrin/ILK signaling by α3 integrin-dependent Src/p-β-catenin-Y654/p-Smad2-mediated up-regulation of ILK through which loss of E-cadherin leads to kidney fibrosis., (Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
31. CD103+ Dendritic Cells Elicit CD8+ T Cell Responses to Accelerate Kidney Injury in Adriamycin Nephropathy.
- Author
-
Cao Q, Lu J, Li Q, Wang C, Wang XM, Lee VW, Wang C, Nguyen H, Zheng G, Zhao Y, Alexander SI, Wang Y, and Harris DC
- Subjects
- Animals, Mice, Antibiotics, Antineoplastic adverse effects, Antigens, CD immunology, CD8-Positive T-Lymphocytes immunology, Dendritic Cells immunology, Doxorubicin adverse effects, Integrin alpha Chains immunology, Kidney Diseases chemically induced, Kidney Diseases immunology
- Abstract
CD103(+) dendritic cells (DCs) in nonlymphoid organs exhibit two main functions: maintaining tolerance by induction of regulatory T cells and protecting against tissue infection through cross-presentation of foreign antigens to CD8(+) T cells. However, the role of CD103(+) DCs in kidney disease is unknown. In this study, we show that CD103(+) DCs are one of four subpopulations of renal mononuclear phagocytes in normal kidneys. CD103(+) DCs expressed DC-specific surface markers, transcription factors, and growth factor receptors and were found in the kidney cortex but not in the medulla. The number of kidney CD103(+) DCs was significantly higher in mice with adriamycin nephropathy (AN) than in normal mice, and depletion of CD103(+) DCs attenuated kidney injury in AN mice. In vitro, kidney CD103(+) DCs preferentially primed CD8(+) T cells and did not directly induce tubular epithelial cell apoptosis. Adoptive transfer of CD8(+) T cells significantly exacerbated kidney injury in AN SCID mice, whereas depletion of CD103(+) DCs in these mice impaired activation and proliferation of transfused CD8(+) T cells and prevented the exacerbation of kidney injury associated with this transfusion. In conclusion, kidney CD103(+) DCs display a pathogenic role in murine CKD via activation of CD8(+) T cells., (Copyright © 2016 by the American Society of Nephrology.)
- Published
- 2016
- Full Text
- View/download PDF
32. IL-25 Elicits Innate Lymphoid Cells and Multipotent Progenitor Type 2 Cells That Reduce Renal Ischemic/Reperfusion Injury.
- Author
-
Huang Q, Niu Z, Tan J, Yang J, Liu Y, Ma H, Lee VW, Sun S, Song X, Guo M, Wang Y, and Cao Q
- Subjects
- Acute Kidney Injury etiology, Adoptive Transfer, Animals, Cell Survival, Cells, Cultured, Immunity, Innate drug effects, Immunity, Innate immunology, Immunologic Factors pharmacology, Interleukin-13 metabolism, Interleukin-17 pharmacology, Interleukin-4 metabolism, Interleukin-5 metabolism, Kidney blood supply, Kidney metabolism, Lymphocytes cytology, Macrophages drug effects, Male, Mice, Mice, Inbred BALB C, Multipotent Stem Cells cytology, Reperfusion Injury complications, Th2 Cells immunology, Acute Kidney Injury immunology, Acute Kidney Injury prevention & control, Immunologic Factors therapeutic use, Interleukin-17 therapeutic use, Lymphocytes drug effects, Multipotent Stem Cells drug effects, Reperfusion Injury immunology, Reperfusion Injury prevention & control
- Abstract
IL-25 is an important immune regulator that can promote Th2 immune response-dependent immunity, inflammation, and tissue repair in asthma, intestinal infection, and autoimmune diseases. In this study, we examined the effects of IL-25 in renal ischemic/reperfusion injury (IRI). Treating IRI mice with IL-25 significantly improved renal function and reduced renal injury. Furthermore, IL-25 treatment increased the levels of IL-4, IL-5, and IL-13 in serum and kidney and promoted induction of alternatively activated (M2) macrophages in kidney. Notably, IL-25 treatment also increased the frequency of type 2 innate lymphoid cells (ILC2s) and multipotent progenitor type 2 (MPP(type2)) cells in kidney. IL-25-responsive ILC2 and MPP(type2) cells produced greater amounts of Th2 cytokines that associated with the induction of M2 macrophages and suppression of classically activated (M1) macrophages in vitro. Finally, adoptive transfer of ILC2s or MPP(type2) cells not only reduced renal functional and histologic injury in IRI mice but also induced M2 macrophages in kidney. In conclusion, our data identify a mechanism whereby IL-25-elicited ILC2 and MPP(type2) cells regulate macrophage phenotype in kidney and prevent renal IRI., (Copyright © 2015 by the American Society of Nephrology.)
- Published
- 2015
- Full Text
- View/download PDF
33. Heymann nephritis in Lewis rats.
- Author
-
Wang YM, Lee VWS, Wu H, Harris DCH, and Alexander SI
- Subjects
- Animals, Biopsy, Disease Models, Animal, Heymann Nephritis Antigenic Complex administration & dosage, Heymann Nephritis Antigenic Complex immunology, Male, Rats, Rats, Inbred Lew, Glomerulonephritis, Membranous etiology, Glomerulonephritis, Membranous pathology
- Abstract
Human membranous nephritis is a major cause of end-stage kidney disease. Active Heymann nephritis (HN) is an auto-immune model of membranous nephritis induced in Lewis rats by immunization with a crude renal tubular antigen (Fx1A) or megalin (gp330). The pathogenesis of HN is through the binding of anti-Fx1A autoantibodies to the auto-antigen expressed on glomerular epithelial cells, resulting in severe glomerular injury and proteinuria. The pathological features of HN include immune deposits in glomeruli and infiltration of glomeruli and the tubulointerstitium by macrophages and T cells. This unit describes the method of the preparation of Fx1A and the induction of HN in Lewis rats by immunization with Fx1A., (Copyright © 2015 John Wiley & Sons, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
34. Renal F4/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy.
- Author
-
Cao Q, Wang Y, Wang XM, Lu J, Lee VW, Ye Q, Nguyen H, Zheng G, Zhao Y, Alexander SI, and Harris DC
- Subjects
- Adoptive Transfer, Animals, Antigens, CD metabolism, Antigens, Differentiation, Myelomonocytic metabolism, Biomarkers metabolism, Disease Models, Animal, Doxorubicin adverse effects, In Vitro Techniques, Kidney physiology, Kidney Diseases chemically induced, Kidney Diseases physiopathology, Lectins, C-Type metabolism, Macrophages immunology, Macrophages physiology, Mannose Receptor, Mannose-Binding Lectins metabolism, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Phagocytes immunology, Phagocytes physiology, Receptors, Cell Surface metabolism, Scavenger Receptors, Class A metabolism, Antigens, Differentiation metabolism, CD11 Antigens metabolism, Kidney pathology, Kidney Diseases pathology, Macrophages pathology, Phagocytes pathology, Phenotype
- Abstract
Conventional markers of macrophages (Mфs) and dendritic cells (DCs) lack specificity and often overlap, leading to confusion and controversy regarding the precise function of these cells in kidney and other diseases. This study aimed to identify the phenotype and function of renal mononuclear phagocytes (rMPs) expressing key markers of both Mфs and DCs. F4/80(+)CD11c(+) cells accounted for 45% of total rMPs in normal kidneys and in those from mice with Adriamycin nephropathy (AN). Despite expression of the DC marker CD11c, these double-positive rMPs displayed the features of Mфs, including Mф-like morphology, high expression of CD68, CD204, and CD206, and high phagocytic ability but low antigen-presenting ability. F4/80(+)CD11c(+) cells were found in the cortex but not in the medulla of the kidney. In AN, F4/80(+)CD11c(+) cells displayed an M1 Mф phenotype with high expression of inflammatory mediators and costimulatory factors. Adoptive transfer of F4/80(+)CD11c(+) cells separated from diseased kidney aggravated renal injury in AN mice. Furthermore, adoptive transfer of common progenitors revealed that kidney F4/80(+)CD11c(+) cells were derived predominantly from monocytes, but not from pre-DCs. In conclusion, renal F4/80(+)CD11c(+) cells are a major subset of rMPs and display Mф-like phenotypic and functional characteristics in health and in AN., (Copyright © 2015 by the American Society of Nephrology.)
- Published
- 2015
- Full Text
- View/download PDF
35. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease.
- Author
-
Lu J, Cao Q, Zheng D, Sun Y, Wang C, Yu X, Wang Y, Lee VW, Zheng G, Tan TK, Wang X, Alexander SI, Harris DC, and Wang Y
- Subjects
- Animals, Cell Differentiation physiology, Cells, Cultured, Disease Management, Disease Models, Animal, Doxorubicin adverse effects, In Vitro Techniques, Macrophages cytology, Male, Mice, Mice, Inbred BALB C, Nephrosis chemically induced, Nephrosis physiopathology, Nephrosis prevention & control, Phenotype, Renal Insufficiency, Chronic pathology, Renal Insufficiency, Chronic physiopathology, T-Lymphocytes, Regulatory cytology, T-Lymphocytes, Regulatory physiology, Adoptive Transfer methods, Cell- and Tissue-Based Therapy methods, Macrophages classification, Macrophages physiology, Renal Insufficiency, Chronic therapy
- Abstract
Two types of alternatively activated macrophages, M(2a) induced by IL-4/IL-13 and M(2c) by IL-10/TGF-β, exhibit anti-inflammatory functions in vitro and protect against renal injury in vivo. Since their relative therapeutic efficacy is unclear, we compared the effects of these two macrophage subsets in murine adriamycin nephrosis. Both subsets significantly reduced renal inflammation and renal injury; however, M(2c) macrophages more effectively reduced glomerulosclerosis, tubular atrophy, interstitial expansion, and proteinuria than M(2a) macrophages. The M(2c) macrophages were also more effective than M(2a) in reduction of macrophage and CD4(+) T-cell infiltration in kidney. Moreover, nephrotic mice treated with M(2c) had a greater reduction in renal fibrosis than those treated with M(2a). M(2c) but not M(2a) macrophages induced regulatory T cells (Tregs) from CD4(+)CD25(-) T cells in vitro, and increased Treg numbers in local draining lymph nodes of nephrotic mice. To determine whether the greater protection with M(2c) was due to their capability to induce Tregs, the Tregs were depleted by PC61 antibody in nephrotic mice treated with M(2a) or M(2c). Treg depletion diminished the superior effects of M(2c) compared to M(2a) in protection against renal injury, inflammatory infiltrates, and renal fibrosis. Thus, M(2c) are more potent than M(2a) macrophages in protecting against renal injury due to their ability to induce Tregs.
- Published
- 2013
- Full Text
- View/download PDF
36. Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage.
- Author
-
Tan TK, Zheng G, Hsu TT, Lee SR, Zhang J, Zhao Y, Tian X, Wang Y, Wang YM, Cao Q, Wang Y, Lee VW, Wang C, Zheng D, Alexander SI, Thompson E, and Harris DC
- Subjects
- Animals, Cell Movement, Cells, Cultured, Epithelial Cells physiology, Epithelial-Mesenchymal Transition, Fibrosis, Kidney metabolism, Kidney Diseases metabolism, Kidney Diseases pathology, Macrophages physiology, Mice, Mice, Inbred BALB C, Snail Family Transcription Factors, Transcription Factors metabolism, beta Catenin metabolism, Kidney pathology, Kidney Diseases immunology, Matrix Metalloproteinase 9 metabolism, Osteopontin metabolism, Ureteral Obstruction metabolism
- Abstract
A pro-fibrotic role of matrix metalloproteinase-9 (MMP-9) in tubular cell epithelial-mesenchymal transition (EMT) is well established in renal fibrosis; however studies from our group and others have demonstrated some previously unrecognized complexity of MMP-9 that has been overlooked in renal fibrosis. Therefore, the aim of this study was to determine the expression pattern, origin and the exact mechanism underlying the contribution of MMP-9 to unilateral ureteral obstruction (UUO), a well-established model of renal fibrosis via MMP-9 inhibition. Renal MMP-9 expression in BALB/c mice with UUO was examined on day 1, 3, 5, 7, 9, 11 and 14. To inhibit MMP-9 activity, MMP-2/9 inhibitor or MMP-9-neutralizing antibody was administered daily for 4 consecutive days from day 0-3, 6-9 or 10-13 and tissues harvested at day 14. In UUO, there was a bi-phasic early- and late-stage upregulation of MMP-9 activity. Interestingly, tubular epithelial cells (TECs) were the predominant source of MMP-9 during early stage, whereas TECs, macrophages and myofibroblasts produced MMP-9 during late-stage UUO. Early- and late-stage inhibition of MMP-9 in UUO mice significantly reduced tubular cell EMT and renal fibrosis. Moreover, MMP-9 inhibition caused a significant reduction in MMP-9-cleaved osteopontin and macrophage infiltration in UUO kidney. Our in vitro study showed MMP-9-cleaved osteopontin enhanced macrophage transwell migration and MMP-9 of both primary TEC and macrophage induced tubular cell EMT. In summary, our result suggests that MMP-9 of both TEC and macrophage origin may directly or indirectly contribute to the pathogenesis of renal fibrosis via osteopontin cleavage, which, in turn further recruit macrophage and induce tubular cell EMT. Our study also highlights the time dependency of its expression and the potential of stage-specific inhibition strategy against renal fibrosis.
- Published
- 2013
- Full Text
- View/download PDF
37. The role of the immune system in the pathogenesis of hypertension.
- Author
-
Lee VW, Wang Y, and Harris DC
- Subjects
- Humans, Lymphocytes physiology, Macrophages physiology, Hypertension etiology, Immune System physiology
- Abstract
The role of innate and adaptive immunity in the pathogenesis of hypertension has received increasing recognition over the past few years. This review will focus on recent developments in this emerging area. In particular, the role of macrophages and lymphocytes will be highlighted.
- Published
- 2013
- Full Text
- View/download PDF
38. Regulatory T cells participate in CD39-mediated protection from renal injury.
- Author
-
Wang YM, McRae JL, Robson SC, Cowan PJ, Zhang GY, Hu M, Polhill T, Wang Y, Zheng G, Wang Y, Lee VW, Unwin RJ, Harris DC, Dwyer KM, and Alexander SI
- Subjects
- Adenosine Triphosphate immunology, Adenosine Triphosphate metabolism, Animals, Apoptosis immunology, Creatinine immunology, Creatinine metabolism, Disease Models, Animal, Doxorubicin, Humans, Kidney Diseases chemically induced, Kidney Diseases metabolism, Kidney Tubules immunology, Kidney Tubules metabolism, Leukocytes immunology, Leukocytes metabolism, Male, Mice, Mice, Inbred BALB C, Mice, Transgenic, T-Lymphocyte Subsets immunology, T-Lymphocyte Subsets metabolism, T-Lymphocytes, Regulatory metabolism, Antigens, CD immunology, Antigens, CD metabolism, Apyrase immunology, Apyrase metabolism, Kidney Diseases immunology, T-Lymphocytes, Regulatory immunology
- Abstract
CD39 is an ecto-enzyme that degrades extracellular nucleotides, such as ATP, and is highly expressed on by the vasculature and circulating cells including Foxp3+ regulatory T (Treg) cells. To study the role of purinergic regulation in renal disease, we used the adriamycin nephropathy (AN) mouse model of chronic renal injury, using human CD39-transgenic (hCD39Tg) and wild-type (WT) BALB/c mice. Effects of CD39 expression by Treg cells were assessed in AN by adoptive transfer of CD4(+) CD25(+) and CD4(+) CD25(-) T cells isolated from hCD39Tg and WT mice. hCD39Tg mice were protected from renal injury in AN with decreased urinary protein and serum creatinine, and significantly less renal injury compared with WT mice. While WT CD25(+) and hCD39Tg CD25(-) T cells conferred some protection against AN, hCD39Tg CD25(+) Treg cells offered greater protection. In vitro studies showed direct pro-apoptotic effects of ATP on renal tubular cells. In conclusion, hCD39 expressed by circulating leukocytes and intrinsic renal cells limits innate AN injury. Specifically, CD39 expression by Treg cells contributes to its protective role in renal injury. These findings suggest that extracellular nucleotides mediate AN kidney injury and that CD39, expressed by Treg cells and other cells, is protective in this model., (© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2012
- Full Text
- View/download PDF
39. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.
- Author
-
Lee VW and Harris DC
- Subjects
- Animals, Genetic Predisposition to Disease, Glomerulosclerosis, Focal Segmental genetics, Glomerulosclerosis, Focal Segmental pathology, Kidney Glomerulus drug effects, Kidney Glomerulus pathology, Kidney Tubules drug effects, Kidney Tubules pathology, Mice, Rats, Disease Models, Animal, Doxorubicin pharmacology, Glomerulosclerosis, Focal Segmental chemically induced
- Abstract
Adriamycin nephropathy (AN) is a rodent model of chronic kidney disease that has been studied extensively and has enabled a greater understanding of the processes underlying the progression of chronic proteinuric renal disease. AN is characterized by podocyte injury followed by glomerulosclerosis, tubulointerstitial inflammation and fibrosis. Genetic studies have demonstrated a number of loci that alter both risk and severity of renal injury induced by Adriamycin. Adriamycin-induced renal injury has been shown in numerous studies to be modulated by both non-immune and immune factors, and has facilitated further study of mechanisms of tubulointerstitial injury. This review will outline the pharmacological behaviour of Adriamycin, and describe in detail the model of AN, including its key structural characteristics, genetic susceptibility and pathogenesis., (© 2011 The Authors. Nephrology © 2011 Asian Pacific Society of Nephrology.)
- Published
- 2011
- Full Text
- View/download PDF
40. Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus.
- Author
-
Zheng D, Wang Y, Cao Q, Lee VW, Zheng G, Sun Y, Tan TK, Wang Y, Alexander SI, and Harris DC
- Subjects
- Animals, Blood Glucose metabolism, Cells, Cultured, Diabetes Mellitus, Experimental blood, Kidney Diseases blood, Kidney Diseases pathology, Male, Mice, Mice, Inbred BALB C, Pancreatic Diseases blood, Pancreatic Diseases pathology, Spleen cytology, Spleen transplantation, Diabetes Mellitus, Experimental therapy, Kidney Diseases therapy, Leukocyte Transfusion methods, Macrophages transplantation, Pancreatic Diseases therapy
- Abstract
Background: Alternatively activated macrophages (M2 macrophages) are able to reduce renal injury in murine adriamycin nephropathy. However, the effect of M2 macrophages in other renal diseases such as diabetic nephropathy remains unknown., Methods: Macrophages were separated from splenocytes and polarized with IL-4 and IL-13 into a protective phenotype. Mice underwent adoptive transfer with M2 macrophages, and then diabetes was induced by tail vein injection with streptozotocin (STZ). Blood glucose levels were monitored daily. Mice were sacrificed at week 10 after STZ. Renal function and histopathological injury were assessed quantitatively., Results: Transfused M2 macrophages accumulated progressively in kidneys for up to 10 weeks after STZ. Kidneys from diabetic mice transfused with M2 macrophages had less tubular atrophy, glomerular hypertrophy and interstitial expansion than did control diabetic mice. M2 macrophages suppressed the development of interstitial fibrosis. In addition, the degree of pancreatic islet injury, as assessed by insulin staining, haemoglobin A1c and blood glucose was reduced after transfusion of M2 macrophages. In vivo, activation of kidney endogenous macrophage cytokine expression was inhibited by M2 macrophages., Conclusion: Our findings show that M2 macrophages can protect against islet and renal injury in streptozotocin-induced diabetes, providing a potential therapeutic strategy for diabetes and diabetic nephropathy., (Copyright © 2011 S. Karger AG, Basel.)
- Published
- 2011
- Full Text
- View/download PDF
41. IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis.
- Author
-
Cao Q, Wang Y, Zheng D, Sun Y, Wang Y, Lee VW, Zheng G, Tan TK, Ince J, Alexander SI, and Harris DC
- Subjects
- Animals, B7-1 Antigen metabolism, CD4-Positive T-Lymphocytes drug effects, CD4-Positive T-Lymphocytes metabolism, CD4-Positive T-Lymphocytes pathology, Cell Proliferation drug effects, Cells, Cultured, Disease Models, Animal, Doxorubicin adverse effects, Kidney drug effects, Kidney metabolism, Kidney pathology, Male, Mice, Mice, Inbred BALB C, Nephrosis chemically induced, Nitric Oxide Synthase Type II metabolism, Phenotype, V-Set Domain-Containing T-Cell Activation Inhibitor 1, Interleukin-10 pharmacology, Macrophages drug effects, Macrophages pathology, Nephrosis physiopathology, Nephrosis prevention & control, T-Lymphocytes, Regulatory pathology, Transforming Growth Factor beta pharmacology
- Abstract
IL-10/TGF-beta-modified macrophages, a subset of activated macrophages, produce anti-inflammatory cytokines, suggesting that they may protect against inflammation-mediated injury. Here, macrophages modified ex vivo by IL-10/TGF-beta (IL-10/TGF-beta Mu2) significantly attenuated renal inflammation, structural injury, and functional decline in murine adriamycin nephrosis (AN). These cells deactivated effector macrophages and inhibited CD4+ T cell proliferation. IL-10/TGF-beta Mu2 expressed high levels of the regulatory co-stimulatory molecule B7-H4, induced regulatory T cells from CD4+CD25- T cells in vitro, and increased the number of regulatory T cells in lymph nodes draining the kidneys in AN. The phenotype of IL-10/TGF-beta Mu2 did not switch to that of effector macrophages in the inflamed kidney, and these cells did not promote fibrosis. Taken together, these data demonstrate that IL-10/TGF-beta-modified macrophages effectively protect against renal injury in AN and may become part of a therapeutic strategy for chronic inflammatory disease.
- Published
- 2010
- Full Text
- View/download PDF
42. The CD40-CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis.
- Author
-
Lee VW, Qin X, Wang Y, Zheng G, Wang Y, Wang Y, Ince J, Tan TK, Kairaitis LK, Alexander SI, and Harris DC
- Subjects
- Animals, Antibodies, Anti-Idiotypic pharmacology, CD40 Antigens antagonists & inhibitors, CD40 Ligand antagonists & inhibitors, Chemokine CCL2 physiology, Cytokines metabolism, Disease Models, Animal, Epithelial Cells drug effects, Epithelial Cells immunology, Epithelial Cells pathology, Kidney Tubules drug effects, Kidney Tubules immunology, Kidney Tubules pathology, Macrophages metabolism, Macrophages pathology, Mesangial Cells metabolism, Mesangial Cells pathology, Mice, Mice, Inbred BALB C, Mice, SCID, Nephrosis pathology, CD40 Antigens physiology, CD40 Ligand physiology, Doxorubicin adverse effects, Immunity, Innate physiology, Nephrosis chemically induced, Nephrosis physiopathology, Signal Transduction physiology
- Abstract
Background: Blockade of CD40-CD40 ligand (CD154) interactions protects against renal injury in adriamycin nephropathy (AN) in immunocompetent mice. To investigate whether this protection relied on adaptive or cognate immunity, we tested the effect of CD40-CD154 blockade in severe combined immunodeficient (SCID) mice., Methods: SCID mice were divided into three groups: normal, AN + hamster IgG (ADR+IgG group) and AN + anti-CD154 antibody (MR1) (ADR+MR1 group). AN was induced by tail vein injection of 5.2 mg/kg of adriamycin (ADR). Hamster IgG (control Ab) or MR1 was administered intraperitoneally on days 5, 7, 9 and 11 after ADR injection. Histological and functional data were collected 4 weeks after ADR injection. In vitro experiments tested the effect of soluble and cell-bound CD154 co-cultured with CD40-expressing cells [macrophages, mesangial cells and renal tubular epithelial cells (RTEC)]., Results: All experimental animals developed nephropathy. Compared to the ADR+IgG group, ADR+MR1 animals had significantly less histological injury (glomerulosclerosis and tubular atrophy) and functional injury (creatinine clearance). Kidneys of ADR+MR1 animals had significantly less macrophage infiltration than those of ADR+IgG animals. Interestingly, expression of CD40 and CD41 (a platelet-specific marker) was significantly less in ADR+MR1 animals compared to ADR+IgG animals. In vitro, CD154 blockade significantly attenuated upregulation of CCL2 gene expression by RTEC stimulated by activated macrophage-conditioned medium. In contrast, platelet-induced upregulation of macrophage and mesangial cell proinflammatory cytokine gene expression were not CD154-dependent., Conclusion: CD40-CD154 blockade has a significant innate renoprotective effect in ADR nephrosis. This is potentially due to inhibition of macrophage-derived soluble CD154.
- Published
- 2010
- Full Text
- View/download PDF
43. Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells.
- Author
-
Tan TK, Zheng G, Hsu TT, Wang Y, Lee VW, Tian X, Wang Y, Cao Q, Wang Y, and Harris DC
- Subjects
- Actins metabolism, Animals, Cell Line, Cells, Cultured, Culture Media, Conditioned pharmacology, Dipeptides pharmacology, Epithelial Cells drug effects, Epithelium pathology, Fibrosis metabolism, Intercellular Signaling Peptides and Proteins metabolism, Lipopolysaccharides pharmacology, Macrophage Activation drug effects, Macrophages drug effects, Macrophages pathology, Matrix Metalloproteinase 2 metabolism, Matrix Metalloproteinase Inhibitors, Mesoderm drug effects, Mesoderm pathology, Mice, Mice, Inbred BALB C, Phenotype, Protein Transport drug effects, Recombinant Proteins pharmacology, Ureteral Obstruction enzymology, Ureteral Obstruction pathology, Epithelial Cells enzymology, Epithelial Cells pathology, Epithelium enzymology, Kidney Tubules pathology, Macrophages enzymology, Matrix Metalloproteinase 9 metabolism, Mesoderm enzymology
- Abstract
As a rich source of pro-fibrogenic growth factors and matrix metalloproteinases (MMPs), macrophages are well-placed to play an important role in renal fibrosis. However, the exact underlying mechanisms and the extent of macrophage involvement are unclear. Tubular cell epithelial-mesenchymal transition (EMT) is an important contributor to renal fibrosis and MMPs to induction of tubular cell EMT. The aim of this study was to investigate the contribution of macrophages and MMPs to induction of tubular cell EMT. The murine C1.1 tubular epithelial cell line and primary tubular epithelial cells were cultured in activated macrophage-conditioned medium (AMCM) derived from lipopolysaccharide-activated J774 macrophages. MMP-9, but not MMP-2 activity was detected in AMCM. AMCM-induced tubular cell EMT in C1.1 cells was inhibited by broad-spectrum MMP inhibitor (GM6001), MMP-2/9 inhibitor, and in AMCM after MMP-9 removal by monoclonal Ab against MMP-9. AMCM-induced EMT in primary tubular epithelial cells was inhibited by MMP-2/9 inhibitor. MMP-9 induced tubular cell EMT in both C1.1 cells and primary tubular epithelial cells. Furthermore, MMP-9 induced tubular cell EMT in C1.1 cells to an extent similar to transforming growth factor-beta. Transforming growth factor-beta-induced tubular cell EMT in C1.1 cells was inhibited by MMP-2/9 inhibitor. Our in vitro study provides evidence that MMPs, specifically MMP-9, secreted by effector macrophages can induce tubular cell EMT and thereby contribute to renal fibrosis.
- Published
- 2010
- Full Text
- View/download PDF
44. Risk factors for oral mucositis in children undergoing chemotherapy: a matched case-control study.
- Author
-
Cheng KK, Goggins WB, Lee VW, and Thompson DR
- Subjects
- Adolescent, Body Weight, Case-Control Studies, Child, Child, Preschool, Female, Humans, Infant, Male, Neoplasms drug therapy, Neutropenia chemically induced, Neutropenia epidemiology, Retrospective Studies, Risk Factors, Stomatitis epidemiology, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols adverse effects, Stomatitis chemically induced
- Abstract
Oral mucositis (OM) is the most frequent and severe complication of chemotherapy for children with cancer, yet little is known about its risk factors. The aim of this study was to determine the risk factors associated with chemotherapy-induced OM in children. A matched case-control design was used. The matching criteria were age, type of cancer and chemotherapy regimen. Patient-and treatment-related data were collected via chart review. Conditional logistic regression analyses were performed to estimate odds ratios (OR) and adjusted odds ratios (AOR) for the development of OM. Fifty-one cases and 51 controls were identified. The mean+/-SD age of the children was 7.6+/-5.2 years, with 65 (63.73%) boys. Eighty-two percent of the children had been diagnosed with haematological malignancies (n=84). The most common chemotherapy regimen was a combination of plant alkaloids and antitumor antibiotics (n=42, 41.18%). In the multivariable model, lower body weight (AOR=0.91; 95% CI=0.84-0.98; p=0.013), lower value of log nadir neutrophil count (AOR=0.33; 95% CI=0.16-0.68; p=0.0025), and higher value of peak creatinine (AOR=1.06; 95% CI=1.01-1.12; p=0.025) were significantly associated with a greater risk of OM. Our findings suggest that children who are neutropenic, those with serum creatinine elevation, and those with a low body weight prior to chemotherapy are at greater risk of developing OM.
- Published
- 2008
- Full Text
- View/download PDF
45. By homing to the kidney, activated macrophages potently exacerbate renal injury.
- Author
-
Wang Y, Wang Y, Cao Q, Zheng G, Lee VW, Zheng D, Li X, Tan TK, and Harris DC
- Subjects
- Adoptive Transfer, Animals, Cells, Cultured, Disease Models, Animal, Doxorubicin, Glomerulosclerosis, Focal Segmental immunology, Glomerulosclerosis, Focal Segmental pathology, Kidney immunology, Macrophage Activation, Macrophages transplantation, Male, Mice, Mice, Inbred BALB C, Mice, SCID, Nephrosis chemically induced, Nephrosis pathology, Kidney pathology, Macrophages immunology, Nephrosis immunology
- Abstract
Macrophages are important mediators of injury in most types of human kidney diseases; however, the pathogenic importance of both macrophage number and activation status is unknown. To examine this question, severe-combined immunodeficient mice with adriamycin nephrosis, an experimental model of human focal segmental glomerulosclerosis, were treated intravenously with either resting (1 x 10(6) to 5 x 10(6)) or activated (1 x 10(3) to 1 x 10(6)) macrophages on day 6 postadriamycin administration, and the effects on kidney injury were examined. On day 28, renal injury was worse in the group that received activated macrophages at doses as low as 1 x 10(4) macrophages per mouse compared with control adriamycin nephrotic mice. However, treatment with resting macrophages at doses as high as 5 x 10(6) macrophages per mouse had no significant effect on either renal histology or function. The transferred activated macrophages homed to inflamed kidneys during the middle-to-late stages of the disease, but such homing was not observed for resting macrophages. This study of in vivo cell adoptive transfer supports the importance of macrophage activation status over macrophage number in causing renal injury. These data suggest that therapeutic strategies for treating progressive kidney diseases should target activated macrophages.
- Published
- 2008
- Full Text
- View/download PDF
46. Regulatory T cells in renal disease.
- Author
-
Wang YM, Hu M, Wang Y, Polhill T, Zhang GY, Wang Y, Lee VW, Harris DC, and Alexander SI
- Abstract
Regulatory T cells (Tregs) have a key role in immune homeostasis and in suppressing unwanted inflammatory responses toward self-antigens. Tregs have been implicated in the control of initial activation events, and play roles in limiting proliferation, differentiation and effector functions of T helper cells. However, the activities of Tregs in the development and progression of kidney disease are not fully elucidated. We have demonstrated the potency of Tregs in animal models of kidney disease. In this review, we summarise mechanistic information from rodent models on the roles of Tregs in glomerular immunopathology and discuss the function of Tregs in diverse kidney diseases. Further studies of Tregs should provide important insights into designing of therapeutic strategies to prevent human kidney disease.
- Published
- 2008
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.